Sanofi begins shipping flu vaccines; Worldwide immunization coverage falls short of 90% goal;

> The first lots of Sanofi's Fluzone vaccine for the 2014-2015 influenza season have been released for distribution. Release

> 84% of the world's infants received vaccines in 2013, missing the Global Vaccine Action Plan's 90% goal, according to WHO. Report

> In a Phase I/IIa trial, Genocea's ($GNCA) herpes vaccine elicited significant, durable T-cell response. Release

> Mymetics ($MYMX) has agreed to manufacture Imugene's cancer vaccine, HER-Vaxx. Story

> Researchers have created a vaccine for dust-mite allergies. More

And Finally... Scientists have identified a biomarker that may predict HIV vaccine efficacy. Story | More from FierceDiagnostics

Suggested Articles

GSK's Shingrix has generated blockbuster sales early in the launch, but there's a lot of remaining opportunity, an exec said at JPM.

Quickly after Merck's world-first Ebola vaccine approval in Europe, U.S. authorities licensed the shot.

In an effort to stop an Ebola outbreak that has claimed 2,200 lives at the Rwanda border, J&J is shipping 200,000 doses of its vaccine to the country.